Stock ISLE ISLEWORTH HEALTHCARE ACQUISITION CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Isleworth Healthcare Acquisition Corp.

Equities

ISLE

US46468P1021

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Isleworth Healthcare Acquisition to Dissolve, Delist After Failing to Combine Business by Sept. 1
MT
Isleworth Healthcare Acquisition Corp.(NasdaqCM:ISLE) dropped from NASDAQ Composite Index
CI
Isleworth Healthcare Acquisition Corp. Announces Cancellation of Special Meeting of Shareholders, Redemption of Public Shares and Subsequent Dissolution
PR
ISLEWORTH HEALTHCARE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Isleworth Healthcare Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Blank Check Firm Isleworth Healthcare Acquisition, Cytovia Scrap Merger Deal
MT
ISLEWORTH AND CYTOVIA TERMINATE MERGER AGREEMENT
PR
Isleworth Healthcare Acquisition : AND CYTOVIA TERMINATE MERGER AGREEMENT - Form 8-K
PU
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Cytovia Therapeutics, Inc. cancelled the acquisition of Isleworth Healthcare Acquisition Corp. from Isleworth Healthcare Sponsor I, LLC and others in a reverse merger transaction.
CI
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibody at EHA 2022 Congress
PR
Isleworth Healthcare Acquisition : Cytovia Therapeutics Appoints Luca Scavo as Chief Financial Officer and James Priour as Chief Product Officer - Form 8-K
PU
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Isleworth Healthcare Acquisition : Quarterly Report (Form 10-Q)
PU
Isleworth Healthcare Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
ISLEWORTH HEALTHCARE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Cytovia Therapeutics to Present In Vivo Multiple Myeloma Data of its CD38-Targeting Flex-NK™ Cell Engager at EHA 2022 Congress
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ISLE Stock
  4. News Isleworth Healthcare Acquisition Corp.